Form 8-K BioRestorative Therapies For: Aug 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BioRestorative Therapies Inc. (BRTX) PT Raised to $18 at Roth/MKM
August 14, 2024 5:08 AM EDTRoth/MKM analyst Jonathan Aschoff raised the price target on BioRestorative Therapies Inc. (NASDAQ: BRTX) to $18.00 (from $15.00) while maintaining a Buy rating.
The analyst comments "BRTX ended 2Q24 with $14.7M in cash. BRTX is observing encouraging Phase 2 BRTX-100 results, and although still... More
